Skip to main content
SpringerLink
Log in

Analgesics and Opioids

  • Chapter
Chronic Pain

Part of the book series: Current Clinical Practice ((CCP))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McQuay HJ, Moore RA, Eccleston C, Morley S, de C Williams AC. Systematic review of outpatient services for chronic pain control. Health Technol Assess 1997;1:1–150

    Google Scholar 

  2. Reid MC, Engles-Horton LL, Weber MB, et al. Use of opioid medications for chronic non-cancer pain syndromes in primary care. J Gen Intern Med 2002;17:173–179

    Article  PubMed  Google Scholar 

  3. Hoogewijs J, Diltoer MW, Hubloue I, et al. A prospective, open, single blind, randomized study comparing four analgesics in the treatment of peripheral injury in the emergency department. Eur J Emerg Med 2000;7:119–123

    CAS  PubMed  Google Scholar 

  4. Kromann-Andersen H, Pedersen A. Reported adverse reactions to and consumption of nonsteroi-dal anti-inflammatory drugs in Denmark over a 17-year period. Dan Med Bull 1988;35:187–192

    CAS  PubMed  Google Scholar 

  5. Matzke GR. Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents. Am J Kidney Dis 1996;28(1 Suppl 1):S63–S70

    Article  CAS  PubMed  Google Scholar 

  6. McGoldrick MD, Bailie GR. Nonnarcotic analgesics: prevalence and estimated economic impact of toxicities. Ann Pharmacother 1997;31:221–227

    CAS  PubMed  Google Scholar 

  7. Lapane KL, Spooner JJ, Pettitt D. The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis. Am J Manage Care 2001;7:402–408

    CAS  Google Scholar 

  8. Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial. JAMA 1999;282:1921–1928

    Article  CAS  PubMed  Google Scholar 

  9. Funk CD, Fitzgerald GA. COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol 2007;50:470–479

    Article  CAS  PubMed  Google Scholar 

  10. Wong M, Chowienczyk P, Kirkham B. Cardiovascular issues of COX-2 inhibitors and NSAIDs. Aust Fam Physician 2005;34:945–948

    PubMed  Google Scholar 

  11. Segasothy M, Chin GL, Sia KK, et al. Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis. Br J Rheumatol 1995;34:162–165

    Article  CAS  PubMed  Google Scholar 

  12. Segasothy M, Samad SA, Zulfigar A, Bennett WM. Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994;24:17–24

    CAS  PubMed  Google Scholar 

  13. LeLorier J, Bombardier C, Burgess E, et al. Practical considerations for the use of nonsteroi-dal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. Can J Cardiol 2002;18:1301–1308

    CAS  PubMed  Google Scholar 

  14. Deider J, Stampfer MJ, Hankison SE, Willett WC, Speizer FE, Curhan GC. Nonnarcotic analgesic use and risk of hypertension in US women. Hypertension 2002;40:604–608

    Article  Google Scholar 

  15. Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med 2007;167:394–399

    Article  PubMed  Google Scholar 

  16. Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Int Med 1998;158:1108–1112

    Article  CAS  Google Scholar 

  17. Friedman DP. Perspectives on the medical use of drugs of abuse. J Pain Symptom Manage 1990;5 (suppl):S2–S5

    CAS  PubMed  Google Scholar 

  18. Shannon CN, Baranowski AP. Use of opioids in non-cancer pain. Br J Hosp Med 1997;5: 459–463

    Google Scholar 

  19. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999;83: 761–786

    Article  CAS  PubMed  Google Scholar 

  20. Mantyselka P, Ahonen R, Kumpusalo E, Takala J. Variability in prescribing for musculo-skeletal pain in Finnish primary health care. Pharm World Sci 2001;23:232–236

    Article  CAS  PubMed  Google Scholar 

  21. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002;23:131–137

    Article  PubMed  Google Scholar 

  22. Eriksen J, Jensen MK, Sjøgren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003;106:221–228

    Article  PubMed  Google Scholar 

  23. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain: a randomized prospective study. Spine 1998;23:2591–2600

    Article  CAS  PubMed  Google Scholar 

  24. Roth SH, Fleischman RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Placebo-controlled trial and long-term evaluation. Arch Intern Med 2000;160:853–860

    Article  CAS  PubMed  Google Scholar 

  25. Schofferman J. Long-term opioid analgesic therapy for refractory lumbar spine pain. Clin J Pain 1999;15:136–140

    Article  CAS  PubMed  Google Scholar 

  26. Eckhardt K, Ammon S, Hofmann U, et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000;91:185–191

    Article  CAS  PubMed  Google Scholar 

  27. Staats PS, Markowitz J, Schein J. Incidence of constipation associated with long-acting opioid therapy: a comparative study. South Med J 2004;97:129–134

    Article  PubMed  Google Scholar 

  28. Cherny NI, Thaler HT, Friedlander-Klar H, et al. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology 1994;44:857–861

    CAS  PubMed  Google Scholar 

  29. Benedetti F, Vighetti S, Amanzio M, et al. Dose-response relationship of opioids in nocicep-tive and neuropathic postoperative pain. Pain 1998;74:205–211

    Article  CAS  PubMed  Google Scholar 

  30. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002;17:173–179

    Article  PubMed  Google Scholar 

  31. Chabal C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 1997;13:150–155

    Article  CAS  PubMed  Google Scholar 

  32. Ossipov MH, Lai J, Vanderah TW, Porreca F. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 2003;73:783–800

    Article  CAS  PubMed  Google Scholar 

  33. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003;106:151–158

    Article  CAS  PubMed  Google Scholar 

  34. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250–1256

    Article  CAS  PubMed  Google Scholar 

  35. Coluzzi F, Mattia C. Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants. Curr Pharm Des 2005;11:2945–2960

    Article  CAS  PubMed  Google Scholar 

  36. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931–1937

    Article  CAS  PubMed  Google Scholar 

  37. Hair PI, Keating GM, Mckeage K. Transdermal matrix fentanyl membrane patch (Matrifen) in severe cancer-related chronic pain. Drugs 2008;68:2001–2009

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

    Dawn A. Marcus M.D.

Authors
  1. Dawn A. Marcus M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Marcus, D.A. (2009). Analgesics and Opioids. In: Chronic Pain. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-60327-465-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-465-4_19

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-464-7

  • Online ISBN: 978-1-60327-465-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation